SomaLogic (not doing cancer yet)

Protein analysis technology for biomarker discovery, currently a research resource rather than a cancer test.

Vetted listing

Testing

Consented intake · your records travel with you · nothing moves without your sign-off

Why SomaLogic exists

SomaLogic provides proteomics, mapping and analyzing proteins from blood or FFPE input. Proteomic analysis can model the signature pathways of cancer cells to identify biomarkers that inform treatment. SomaLogic is not yet offering cancer-specific testing, so for a patient deciding now it represents a research avenue rather than a clinical option.

CLIA certified, CAP accredited laboratoryPart of Standard BioTools

Prefer the source? SomaLogic (not doing cancer yet)'s own site has more.

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how SomaLogic (not doing cancer yet) handles billing.

We don't have confirmed insurance details for SomaLogic (not doing cancer yet) yet. Start a coverage check with your plan, or contact the provider directly.

Ask about this service

Answers grounded in SomaLogic's details here. Educational only; your oncologist directs treatment.

Ask OpenCancer · answers grounded in this storefront

Also consider

Other providers in similar categories.

BostonGene

6 offerings

Gather distinctive biomarkers that can guide treatment and monitor disease progression

Foundation Medicine

6 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.